ClinicalTrials.gov
public full text
Public Domain
SA4503 8-Week Study in Major Depressive Disorder (MDD)
The purpose of this study is to determine the efficacy of SA4503 compared to placebo in the treatment of subjects with major depressive disorder (MDD). Secondary, to evaluate the safety of SA4503 compared to placebo in subjects with MDD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant#895589
- A Safety Study in Participants With Major Depressive Disorder#897863
- Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial#893749
- Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.#838205
- Tolerability, Safety and Efficacy of Vortioxetine#1125453
Record · ID 855890
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive